Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
67 | Contract Pharma | trade journal | 0.100 Q4 | 4 | 157 | 249 | 264 | 7 | 200 | 0.03 | 1.68 | |
66 | European Life Science Journal | trade journal | 0.100 Q4 | 1 | 16 | 121 | 0 | 0 | 119 | 0.00 | 0.00 | |
65 | Life Science Clusters | trade journal | 0.100 Q4 | 0 | 0 | 71 | 0 | 0 | 65 | 0.00 | 0.00 | |
64 | Therapeutic Innovation and Regulatory Science | journal | 0.100 Q4 | 51 | 145 | 417 | 1971 | 133 | 405 | 0.25 | 13.59 | |
63 | Pharmacometrics | journal | 0.101 Q4 | 7 | 16 | 39 | 219 | 1 | 39 | 0.03 | 13.69 | |
62 | PharmacoVigilance Review | journal | 0.101 Q4 | 2 | 23 | 23 | 53 | 0 | 18 | 0.00 | 2.30 | |
61 | Quality Assurance Journal | journal | 0.101 Q4 | 11 | 13 | 32 | 163 | 5 | 29 | 0.16 | 12.54 | |
60 | European Pharmaceutical Review | trade journal | 0.104 Q4 | 9 | 30 | 72 | 542 | 5 | 64 | 0.07 | 18.07 | |
59 | Milestones in Drug Therapy | book series | 0.104 Q4 | 6 | 18 | 41 | 1246 | 2 | 41 | 0.05 | 69.22 | |
58 | European Pharmaceutical Journal | journal | 0.106 Q4 | 9 | 10 | 33 | 213 | 3 | 31 | 0.09 | 21.30 | |
57 | Pharmacoeconomics - Spanish Research Articles | journal | 0.107 Q4 | 6 | 12 | 45 | 394 | 5 | 38 | 0.16 | 32.83 | |
56 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.108 Q4 | 3 | 77 | 138 | 96 | 4 | 137 | 0.03 | 1.25 | |
55 | Methods in Pharmacology and Toxicology | book series | 0.112 Q4 | 14 | 0 | 22 | 0 | 4 | 21 | 0.00 | 0.00 | |
54 | NATO Security through Science Series A: Chemistry and Biology | book series | 0.114 Q4 | 15 | 0 | 26 | 0 | 9 | 26 | 0.00 | 0.00 | |
53 | Arzneimitteltherapie | journal | 0.118 Q4 | 6 | 141 | 438 | 1075 | 15 | 201 | 0.03 | 7.62 | |
52 | Pharmaceutical Processing | trade journal | 0.119 Q4 | 4 | 44 | 108 | 44 | 8 | 87 | 0.07 | 1.00 | |
51 | Currents in Pharmacy Teaching and Learning | journal | 0.120 Q4 | 31 | 47 | 52 | 936 | 14 | 45 | 0.27 | 19.91 | |
50 | Antibiotics | journal | 0.121 Q4 | 77 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | |
49 | Regulatory Rapporteur | trade journal | 0.129 Q3 | 7 | 59 | 76 | 375 | 5 | 55 | 0.07 | 6.36 | |
48 | Open Drug Safety Journal | journal | 0.134 Q3 | 3 | 9 | 1 | 289 | 1 | 1 | 1.00 | 32.11 | |
47 | Drug Discoveries and Therapeutics | journal | 0.137 Q3 | 31 | 49 | 52 | 1770 | 17 | 52 | 0.33 | 36.12 | |
46 | EJHP Practice | trade journal | 0.138 Q3 | 6 | 92 | 221 | 722 | 29 | 170 | 0.14 | 7.85 | |
45 | Hacettepe University Journal of the Faculty of Pharmacy | journal | 0.144 Q3 | 9 | 11 | 37 | 415 | 12 | 37 | 0.20 | 37.73 | |
44 | Botulinum Journal | journal | 0.146 Q3 | 6 | 7 | 16 | 186 | 3 | 14 | 0.19 | 26.57 | |
43 | Trends in Medical Research (discontinued) | journal | 0.146 Q3 | 11 | 14 | 25 | 428 | 18 | 25 | 1.07 | 30.57 | |
42 | Journal of Pharmaceutical Policy and Practice | journal | 0.153 Q3 | 32 | 18 | 15 | 436 | 9 | 10 | 0.60 | 24.22 | |
41 | Journal of Pharmaceutical Health Services Research | journal | 0.154 Q3 | 19 | 35 | 29 | 895 | 6 | 25 | 0.21 | 25.57 | |
40 | Pharmaceuticals Policy and Law | journal | 0.154 Q3 | 11 | 28 | 119 | 489 | 24 | 113 | 0.15 | 17.46 | |
39 | Vitae | journal | 0.156 Q3 | 19 | 36 | 67 | 1118 | 25 | 63 | 0.37 | 31.06 | |
38 | Drug Target Insights | journal | 0.161 Q3 | 16 | 2 | 15 | 83 | 2 | 15 | 0.00 | 41.50 | |
37 | PharmacoEconomics - German Research Articles | journal | 0.161 Q3 | 5 | 4 | 9 | 81 | 3 | 8 | 0.33 | 20.25 | |
36 | Neuropsychopharmacologia Hungarica | journal | 0.166 Q2 | 18 | 30 | 78 | 1038 | 35 | 66 | 0.48 | 34.60 | |
35 | Open Access Journal of Clinical Trials | journal | 0.172 Q2 | 15 | 12 | 22 | 266 | 19 | 22 | 0.86 | 22.17 | |
34 | Neuromethods | book series | 0.185 Q2 | 24 | 300 | 140 | 19806 | 63 | 127 | 0.45 | 66.02 | |
33 | Journal of Medical Marketing | journal | 0.195 Q2 | 20 | 40 | 128 | 852 | 30 | 111 | 0.18 | 21.30 | |
32 | Molecular and Cellular Toxicology | journal | 0.218 Q2 | 28 | 50 | 50 | 1451 | 50 | 50 | 1.00 | 29.02 | |
31 | Journal of Negative Results in BioMedicine | journal | 0.269 Q2 | 25 | 16 | 34 | 376 | 34 | 33 | 0.77 | 23.50 | |
30 | Advances in Pharmacological Sciences | journal | 0.270 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
29 | Journal of Pharmacology and Toxicology (discontinued) | journal | 0.283 Q2 | 22 | 58 | 99 | 2084 | 100 | 99 | 1.26 | 35.93 | |
28 | Expert Review of Clinical Pharmacology | journal | 0.297 Q2 | 60 | 69 | 197 | 5043 | 143 | 167 | 0.77 | 73.09 | |
27 | Archives of Drug Information | journal | 0.301 Q2 | 12 | 4 | 31 | 73 | 33 | 30 | 1.47 | 18.25 | |
26 | Marmara Pharmaceutical Journal | journal | 0.302 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
25 | American Journal of Pharmacy Benefits | journal | 0.313 Q2 | 16 | 54 | 56 | 1250 | 14 | 42 | 0.25 | 23.15 | |
24 | Medicinal Chemistry Research | journal | 0.314 Q2 | 59 | 213 | 228 | 5609 | 280 | 228 | 1.19 | 26.33 | |
23 | American Journal of Pharmacology and Toxicology (discontinued) | journal | 0.391 Q1 | 24 | 17 | 72 | 377 | 98 | 72 | 1.35 | 22.18 | |
22 | American Journal of Pharmaceutical Education | journal | 0.412 Q1 | 78 | 233 | 541 | 3476 | 696 | 464 | 1.07 | 14.92 | |
21 | Patient Preference and Adherence | journal | 0.454 Q1 | 67 | 71 | 120 | 2594 | 187 | 119 | 1.69 | 36.54 | |
20 | F1000 Biology Reports | journal | 0.502 Q1 | 32 | 26 | 88 | 1102 | 77 | 87 | 0.88 | 42.38 | |
19 | Therapeutics and Clinical Risk Management | journal | 0.540 Q1 | 70 | 8 | 265 | 353 | 630 | 264 | 2.71 | 44.13 | |
18 | Drug Metabolism and Personalized Therapy | journal | 0.543 Q1 | 38 | 27 | 42 | 1056 | 88 | 41 | 0.96 | 39.11 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®